Fundology

OMXCOP: GMAB · Health Technology

Which UK funds hold Genmab A/S (GMAB)?

Genmab A/S (GMAB) is among the ten largest holdings of 8 UK funds Fundology covers, according to the holdings each fund publishes. In the largest of these funds by size, it makes up 0.14% of MWEP (Invesco MSCI World Equal Weight UCITS ETF Acc AccumUSD), 2.48% of DRDR (iShares Healthcare Innovation UCITS ETF) and 1.03% of AGES (iShares Ageing Population UCITS ETF). The largest weight is 2.48%, in DRDR (iShares Healthcare Innovation UCITS ETF), as of 06/11/2026. In all, 135 funds list it among their published holdings. 18 swap-based funds also list Genmab A/S (GMAB) in the substitute baskets they hold as collateral; they track different indices through swaps and are not counted as holders.

UK funds that hold Genmab A/S

Funds where it is one of the ten largest holdings, largest weight first. A weight is the share of the fund’s money in this company.

UK funds holding Genmab A/S, with the company’s weight in each fund and the date of the holdings
FundWeight in the fundHoldings as of
DRDR · iShares Healthcare Innovation UCITS ETFIE00BYZK47762.48%
EUMD · iShares MSCI Europe Mid Cap UCITS ETF Accum Unhedged EURIE00BF20LF40 · one portfolio, 2 share classes1.30%
AGES · iShares Ageing Population UCITS ETFIE00BYZK46691.03%
IEFS · iShares MSCI Europe Mid-Cap Equal Weight UCITS ETFIE00BQN1KC320.92%
MEEQ · Invesco MSCI Europe Equal Weight UCITS ETF AccumEURIE000LUZJNI70.43%
IWFS · iShares MSCI World Mid-Cap Equal Weight UCITS ETF USDIE00BP3QZD730.27%
WEWE · BNP Paribas Easy MSCI World Equal Weight Select UCITS ETF Accum-CAP- Unhedged USDIE000ALI2E450.16%
MWEP · Invesco MSCI World Equal Weight UCITS ETF Acc AccumUSDIE000OEF25S10.14%

Holdings dates differ by fund

Funds that hold it further down

127 more funds list Genmab A/S below their ten largest holdings.

Create a free account to see every fund that holds this company, at any weight

Sign-up takes an email address. There is no card to enter and nothing to pay.

About Genmab A/S

Genmab A/S is listed on OMXCOP under the symbol GMAB, in the health technology sector. Its market value was about $31.1bn (in US dollars) on 13/11/2026.

A fund’s weight in a company is the share of the fund’s money held in that company’s shares. A weight of 5% in a fund worth £1 billion is about £50 million. Index funds hold companies in proportion to their size in the index, so the largest companies appear in many funds at similar weights.

The list above is drawn from the funds’ published holdings, each dated, and names the funds where Genmab A/S is one of the ten largest holdings — the part of every fund page open to anyone. Some funds publish only their largest ten, so a fund can hold Genmab A/S without it appearing in any list here. When two funds both hold the same large companies, owning both can be closer to owning one than it looks: the comparison page measures that overlap when both funds publish enough of their holdings.

Share price

Latest price
3,448.00 DKK
−2.32%on the day
52-week range
1,512.00 DKK–3,947.00 DKK
Price change, 1 year
+75.3%
Price change, this year
+72.8%
Market value
$31.1bn
Price to earnings (12 months)
45.7
Dividend yield (12 months)
0.00%

As of , at least 15 min delayed